Apellis Pharmaceuticals Inc

NASDAQ:APLS  
41.70
-1.98 (-4.53%)
Earnings Announcements

Apellis Pharma Reports Q3 2021 Financial Results

Published: 11/08/2021 21:38 GMT
Apellis Pharmaceuticals Inc (APLS) - Apellis Pharmaceuticals Reports Third Quarter 2021 Financial Results.
Q3 Revenue $5.7 Million.
Qtrly Loss per Share $2.28.
Revenue is expected to be $13.98 Million
Adjusted EPS is expected to be -$1.46

Next Quarter Revenue Guidance is expected to be $25.28 Million
Next Quarter EPS Guidance is expected to be -$1.41

More details on our Analysts Page.